Lazard Asset Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $878K | Buy |
78,885
+75,786
| +2,445% | +$844K | ﹤0.01% | 1341 |
|
|
2025
Q1 | $38K | Sell |
3,099
-308
| -9% | -$3.78K | ﹤0.01% | 2036 |
|
|
2024
Q4 | $38K | Sell |
3,407
-20
| -0.6% | -$223 | ﹤0.01% | 2022 |
|
|
2024
Q3 | $23K | Buy |
3,427
+1
| +0% | +$7 | ﹤0.01% | 1993 |
|
|
2024
Q2 | $25K | Sell |
3,426
-115
| -3% | -$839 | ﹤0.01% | 2005 |
|
|
2024
Q1 | $46K | Sell |
3,541
-388
| -10% | -$5.04K | ﹤0.01% | 1732 |
|
|
2023
Q4 | $40K | Buy |
+3,929
| New | +$40K | ﹤0.01% | 1947 |
|